COVID-19 Test
Find information on COVID-19 testing, including SARS-CoV-2 test, Coronavirus test, and COVID screening. This resource provides details for healthcare professionals on clinical documentation and medical coding related to a COVID-19 diagnosis. Learn about proper coding procedures and documentation requirements for COVID-19 tests for accurate healthcare reporting and reimbursement.
A test to detect active or past SARS-CoV-2 infection.
Fever, cough, shortness of breath, loss of taste or smell, fatigue, body aches.
Testing centers, hospitals, clinics, doctor's offices, at-home testing.
ICD-10 Code Families
Complete code families applicable to Z20.822
When to use each related code
| Description | When to use |
|---|---|
| Tests for active COVID-19 infection. | Suspected COVID-19 infection based on symptoms, exposure, or screening. |
| Detects past COVID-19 infection. | Evaluating prior infection, regardless of symptoms. Useful for epidemiological studies. |
| Quantifies antibodies against SARS-CoV-2. | Assessing immune response after infection or vaccination. Not for diagnosing active infection. |
Best-practice checklist
- ✓Document COVID-19 symptoms onset date.
- ✓Record COVID-19 test type (PCR, Antigen).
- ✓Include test result (positive, negative, inconclusive).
- ✓Specify testing location (e.g., hospital, clinic, POC).
- ✓Note relevant medical history for COVID-19.
Common pitfalls to avoid
Coding requires specifying PCR, Antigen, or Antibody test for accurate reimbursement and data analysis. COVID-19 test alone is insufficient.
Missing documentation of medical necessity, signs/symptoms, or test ordering rationale can lead to claim denials and compliance issues.
Using unlisted or unspecified codes when a specific code exists for the COVID-19 test type may trigger audits and payment delays.
Best-practice tips
- 01Document COVID-19 testing criteria, ICD-10-CM codes (e.g., U07.1) accurately for proper reimbursement.
- 02Ensure compliance with telehealth guidelines for remote COVID-19 testing and reporting.
- 03Implement infection control protocols per CDC guidelines during COVID-19 testing.
- 04Use standardized terminology (SNOMED CT, LOINC) for COVID-19 testing documentation for interoperability.
- 05Regularly audit COVID-19 testing documentation for CDI and compliance with payer guidelines.
Step-by-step checklist
- 1
Verify patient symptoms align with ICD-10-CM U07.1 or U07.2 codes.
- 2
Confirm test type (PCR, Antigen) matches clinical need and documentation.
- 3
Review patient demographics for accurate reporting and contact tracing.
- 4
Check prior test results and vaccination status in patient history.
Ready-to-paste narrative
Patient presents for COVID-19 evaluation due to [reason for testing, e.g., symptoms, exposure, pre-procedural screening]. Symptoms, if present, include [list specific symptoms e.g., cough, fever, shortness of breath, anosmia, ageusia, fatigue, body aches, headache, sore throat, congestion, nausea, vomiting, diarrhea]. Onset of symptoms was [date of symptom onset or "asymptomatic"]. Patient reports [mention relevant travel history, exposures, or pertinent negatives e.g., recent travel to high-risk areas, close contact with confirmed COVID-19 case, no known exposures]. Physical examination reveals [document vital signs e.g., temperature, heart rate, respiratory rate, oxygen saturation, and pertinent findings e.g., clear lung sounds, no respiratory distress]. Assessment: Suspected COVID-19 infection. Plan: SARS-CoV-2 testing via [specify test type e.g., nasopharyngeal swab, PCR, antigen] performed. Patient education provided regarding isolation precautions, symptom management, and follow-up care. Differential diagnosis includes influenza, other respiratory viral infections, and community-acquired pneumonia. ICD-10 code [appropriate ICD-10 code, e.g., U07.1 for COVID-19, confirmed] and CPT code [appropriate CPT code, e.g., 87635 for SARS-CoV-2 RNA test] will be used for billing and coding purposes pending test results. Results will be communicated to the patient and appropriate public health reporting will be performed as indicated. Return for evaluation if symptoms worsen or do not improve within [timeframe, e.g., 7-10 days]. Coronavirus testing and screening procedures were followed in accordance with current CDC guidelines.
Common questions and answers
What are the most reliable COVID-19 test options for differentiating between acute infection and past exposure in symptomatic patients with comorbidities?+
When diagnosing COVID-19 in symptomatic patients with comorbidities, it's crucial to differentiate between acute infection and past exposure. While PCR tests remain the gold standard for detecting active SARS-CoV-2 infection, their sensitivity can wane in the later stages of infection. For patients presenting with symptoms weeks after initial exposure, a combination of PCR and antibody testing may be considered to assess both current infection status and prior immune response. Furthermore, the patient's clinical presentation, including symptom onset and duration, along with underlying comorbidities, should be carefully evaluated in conjunction with test results to guide appropriate management. Explore how incorporating antigen tests can improve triage efficiency in patients with suspected acute COVID-19 infection.
How can clinicians interpret discordant COVID-19 test results (e.g., positive PCR, negative antigen) in a patient suspected of having the Omicron variant?+
Discordant COVID-19 test results, such as a positive PCR and negative antigen test, can present a diagnostic challenge, especially with the emergence of variants like Omicron. Several factors contribute to this discrepancy, including viral load, test sensitivity, and the timing of sample collection. A negative antigen test does not necessarily rule out COVID-19 infection in a symptomatic patient with a positive PCR. Given Omicron's rapid transmission and potential for immune escape, clinicians should consider repeat testing, preferably PCR, within 24-48 hours, alongside a thorough clinical assessment. Consider implementing standardized testing protocols for optimal interpretation of COVID-19 test results in the context of emerging variants. Learn more about the latest CDC guidelines on COVID-19 testing and variant surveillance.
What are the best practices for pre-procedural COVID-19 screening to minimize nosocomial transmission in high-risk surgical settings?+
Minimizing nosocomial transmission of COVID-19 in high-risk surgical settings requires a robust pre-procedural screening strategy. This involves a combination of PCR testing within a specific timeframe prior to the procedure, alongside a thorough assessment of the patient's recent travel history, exposure risks, and symptom profile. For elective procedures, pre-operative isolation and quarantine may be recommended depending on the patient's individual risk factors. Strict adherence to infection control protocols, including universal masking, proper hand hygiene, and environmental disinfection, is essential. Explore how point-of-care testing can be strategically integrated into pre-procedural workflows to improve turnaround time and minimize delays in surgical care.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.